Pharmaceutical Executive November 29, 2022
Contrasting the view of heart failure patients as seen from the perspectives of two large but distinct sources of real-world data: the Veradigm Cardiology Registry and Practice Fusion
Heart failure is becoming an increasingly heavy health burden worldwide, affecting an estimated 23 million people. Classification of heart failure patients depends primarily on the degree of left ventricular systolic dysfunction, which is measured via echocardiography. Once heart failure patients have been identified, many researchers examine the relationship between heart failure and other factors, such as obesity, as measured by body mass index (BMI).
As a result, studying and generating real-world evidence (RWE) related to patients with heart failure requires data not commonly found in administrative claims data. A comparison of two...
Today's Sponsors
Today's Sponsor